Skip to main content
MannKind Corporation (MNKD)
NASDAQ: MNKD · Real-Time Price · USD
2.790
+0.160 (6.08%)
At close: Apr 28, 2026, 4:00 PM EDT
2.800
+0.010 (0.36%)
Pre-market: Apr 29, 2026, 6:55 AM EDT

MannKind Revenue

In the year 2025, MannKind had annual revenue of $348.97M with 22.23% growth. MannKind had revenue of $111.96M in the quarter ending December 31, 2025, with 45.82% growth.

Revenue (ttm)
$348.97M
Revenue Growth
+22.23%
P/S Ratio
2.47
Revenue / Employee
$589,470
Employees
592
Market Cap
861.54M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025348.97M63.46M22.23%
Dec 31, 2024285.50M86.54M43.50%
Dec 31, 2023198.96M99.19M99.42%
Dec 31, 202299.77M24.33M32.25%
Dec 31, 202175.44M10.30M15.81%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Theravance Biopharma 107.46M
ARS Pharmaceuticals 84.28M
MeiraGTx Holdings 81.39M
Kura Oncology 67.48M
Arbutus Biopharma 14.08M
Crescent Biopharma 10.84M
Revenue Rankings

MNKD News

More News